Meyers Michael L. 4
4 · Syndax Pharmaceuticals Inc · Filed Feb 8, 2019
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Other
Common Stock
2019-01-31$4.76/sh+3,720$17,707→ 6,118 total - Award
Stock Option (Right to Buy)
2019-02-06+104,325→ 104,325 totalExercise: $6.38Exp: 2029-02-06→ Common Stock (104,325 underlying)
Footnotes (2)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 3,720 shares by the Reporting Person on 01/31/2019 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]The securities awarded on 02/06/2019 were in the form of stock options issued pursuant to the Syndax Pharmaceuticals, Inc. 2015 Omnibus Incentive Plan. Options to purchase 50,825 shares of common stock shall vest in 48 successive equal monthly installments measured from 02/06/2019. Options to purchase 53,500 shares of common stock shall vest periodically upon the Issuer achieving certain milestones.